INTRODUCTION
Compromising the anatomical and functional integrity of the wall
musculoaponeurosis of the abdomen is a relatively frequent occurrence, with
varying degrees of clinical manifestation, complexity, and causal agent, being
represented mainly by hernias in their different forms by laxity or exaggerated
compliance of the anterior abdominal plane secondary to obesity or pregnancy
and
by post-infection sequelae, trauma or tumor resections.
Data from the public network in Brazil show an annual average of 242 thousand
herniorrhaphies, with 54% corresponding to inguinal hernias, 99.4% being open,
and only 0.6% laparoscopic, with 22% reported as operated in an emergency
situation1. Added to
this are patients operated on in private networks and repairs secondary to other
causes, indicating the magnitude of the problem and requiring an algorithm in
the appropriate selection of the technique to be adopted in the different
corrections2.
Furthermore, diffuse bulging due to laxity of the entire abdominal wall, with
functional and/or aesthetic impairment, is also a common occurrence and not
properly estimated in post-bariatric surgery patients, in pregnancy of
repetition, or women with an android biotype, affecting to varying degrees the
quality of life and work capabilities in a much larger portion of the
population, with great demand for plastic surgeons for treatment. Although
complete in their integrity, these repairs generally require reinforcement with
mesh after plication of the muscular wall due to the thinning of the structures,
preventing a recurrence of protrusion with the functional and cosmetic
compromise of the result3.
Although comorbidity factors such as obesity, diabetes, and smoking can affect
recurrence rates4, the
association of biomaterials made it possible to repair different abdominal wall
defects with significant tension relief concomitant with increased local
resistance, reducing these rates by more than 50% and demonstrating the
mechanical factor as preponderant in the success of repairs5, making the use of
“reinforcement screens” mandatory in these situations.
After decades of using synthetic meshes6, from the 1990s onwards, there was the introduction of
biological membranes of animal or human origin - called
extracellular matrices (ECMs) - thus beginning a new era in
the repair of abdominal wall defects7, with results that stimulated its increasing adoption in
various parts of the world over the last two decades.
Different types of acellularized membranes have been developed from varied
biological tissues - such as human8 or animal dermis9, intestinal mucosa10, bovine fetal tissue11, and bovine pericardium12 - each with relatively
distinct characteristics in terms of clinical and therapeutic applications,
described in countless scientific publications, generally establishing a new
standard of indications in the repair of abdominal wall defects, as well as in
several other areas (Table 1).
Table 1 - Partial list of different acellular matrices of human and animal
origin. All of these products are approved in several countries and
available on the world market for their different applications, with
hundreds of scientific publications demonstrating the evolution and
growing importance of the therapeutic application of extracellular
matrix bioprostheses.
Species of
Origin
|
Origin
Fabric
|
Application |
Name/Manufacturer |
Human |
Dermis |
Soft Parts /
Breast Soft Parts /
Breast Breast/Tendon Breast Soft
Parts Pelvic Organ Prolapse Chronic Wounds
|
AlloDerm /
Lifecell AlloMax / Bard Davol AlloPatch /
Musculosk Foundation Neoform / Mentor
Worldwide GraftJacket / Kinetc Concepts Axis /
Coloplast DermaPure / Regenix Group
|
Fascia Lata |
Ophthalmology Pelvic Organ Prolapse
|
Tutoplast
FL/IOP Suspend / Coloplast
|
Pericardium |
Ophthalmology |
IO Patch /
IOP
|
Bovine |
Dermis |
Soft Parts |
TissueMend / Stryker |
Pericardium |
Breast, Vascular, Dura mater,
Fascia Dentistry Dura mater Heart
Valve
|
Veritas, Dura-Guard,
PeriGuard, Vascu-Guard / BAXTER CopiOs /
Zimmer Lyoplant / B. Braun Melsungen Perimount /
Edwards Lifesciences
|
Porcine |
Dermis |
Soft
Parts/Fascia/Breasts Soft Parts Soft Parts,
Breasts, Fascia
|
Strattice /
LifeCell ColaMend, XenMatrix / Bard Davol Permacol
/ Tissue Science Lab
|
Intestinal
mucosa
|
Breasts,
fascia, Dura mater Nerve Repair Pericardium /
Cardiac Tissue
|
Surgisis,
Durasis, Oasis / Cook Biotech AxoGuard /
AxoGen CorMatrixECM / CorMatrix Cardiov
|
Urinary
bladder
|
Soft
Parts
|
MatriStem/ACell |
Equine |
Pericardium |
Soft Parts /Chronic Wounds |
Unite / Synovis Ort. Wound Care |
Dura mater |
DurAdapt / Pegasus Biologic |
Table 1 - Partial list of different acellular matrices of human and animal
origin. All of these products are approved in several countries and
available on the world market for their different applications, with
hundreds of scientific publications demonstrating the evolution and
growing importance of the therapeutic application of extracellular
matrix bioprostheses.
Using EMCs produced by a company with expertise in the production of bovine
pericardium bioprostheses for 40 years13, this protocol analyzed the application of biological
membranes - called Periwall® - in abdominal wall repair surgery, with
aspects not yet described in humans under normal conditions and no publications
on the subject in the national scientific literature were identified.
OBJECTIVE
The main objective of the study was to observe the functionality of acellular
bovine pericardial membranes in repairing the abdominal wall, as well as
evaluate their similarity with other bioprostheses described in the
literature.
METHOD
From April 2018 to January 2022, thirty patients underwent abdominal wall repair
using the acellular bovine pericardium membrane, 14 men and 16 women, aged
between 29 and 77 years (average=48 years), for different indications and
locations, making a total of 40 anatomically individualized implants, summarized
in Table 2. The minimum follow-up was 10
months, and the maximum was 46 months, with an average of 31 months.
Table 2 - List of different abdominal wall deformities repaired with acellular
bovine pericardium membrane bioprostheses, totaling 30 patients and 40
anatomically individualized implants.
Diagnosis |
Number of Cases |
Number of Implants |
Hernias |
|
|
Unilateral Inguinal |
10 |
10 |
Bilateral Inguinal |
03 |
06 |
Incisional |
04 |
04 |
Umbilical/Paraumbilical |
02 |
02 |
Epigastric |
01 |
01 |
Post Bariatric / Abdominal Wall
Compliance
|
06 |
09 |
Infraumbilical Wall Endometrioma |
01 |
01 |
Associated Deformities |
|
|
Inguinal Hernia + Supra Umbilical
Hernia
|
01 |
02 |
Post Bariatric + Supra Umbilical
Hernia
|
01 |
02 |
Wall Compliance + Bilateral Inguinal
Hernia
|
01 |
03 |
Total |
30 |
40 |
Table 2 - List of different abdominal wall deformities repaired with acellular
bovine pericardium membrane bioprostheses, totaling 30 patients and 40
anatomically individualized implants.
On a multicenter basis and duly approved by CONEP and the Research Ethics
Committees, patients were selected and operated on jointly by the main author
and general surgery teams with expertise in the area at three reference
hospitals in São José do Rio Preto - Beneficência Portuguesa, Hospital do
Coração and Hospital Estadual João Paulo II. All patients received an informed
consent form about the nature of the procedure, describing the mandatory need
for reinforcing mesh to correct the problem and the options available between
the synthetic and biological compounds.
In addition to the main pathology and the classification of the nature of the
surgical wounds, the variables age, Body Mass Index, and any associated
pathologies, important for the study’s inclusion/exclusion criteria, were
recorded. Only two inclusion criteria were used, namely - 1.
Only surgeries classified as “Clean” were admitted and 2. In cases where the
indication corresponded to the conventional standard described in the literature
for the use of synthetic meshes, that is, in surgeries in which the implantation
of abdominal wall reinforcement was mandatory. Pre-operatively, obese patients,
those with contaminated or infected surgical wounds, and those with important
associated comorbidities (high blood pressure, type 1 diabetes, emphysema,
and/or obstructive pulmonary disease) were excluded, with a risk-benefit ratio
considered unfavorable by the medical team.
All patients underwent surgery under general anesthesia, with an average hospital
stay of 1 day, and received antibiotic therapy with cephalosporin 1g per day
for
7 days. The use of a compressive abdominal belt was recommended for 120 days,
as
well as the prohibition of strenuous physical activities during this period.
In addition to monthly clinical monitoring, radiological ultrasound examinations
were performed at different postoperative periods and, in 4 cases,
electromagnetic resonance imaging of the abdominal wall at 9, 11, 17, and 26
months.
In 3 patients, it was possible to take biopsies of the implanted areas at 13, 22,
and 23 months postoperatively. The slides were stained with hematoxylin-eosin,
Gomori’s trichrome, and Picro-Sírius Red and subjected to morphometric
analysis.
Membrane preparation
The membranes were supplied sterile in vials containing 4% formaldehyde,
requiring pre-implantation washing, as recommended by the manufacturer.
Thus, the membrane was placed in a vat containing 0.9% saline solution and
manually shaken, discarding the solution every 5 minutes and repeating the
procedure for 3 cycles, then requiring 15 minutes for the material to be in
terms of use. The “no touch” principles were followed when
handling the implants and preparing the store, with changing and washing
gloves to remove talc residue and re-antisepsis of the surgical site prior
to implantation, thus favoring minimal manipulation. A solution was prepared
containing 1000ml of 0.9% saline solution associated with 2g of
cephalosporin and 80mg of gentamicin, leaving the already washed membrane
immersed in this solution until use. During the fixation process, the same
solution was used to irrigate the entire implantation area at random
periods.
Surgical technique
The membranes were fixed with separate and/or continuous points of
non-absorbable polypropylene (Prolene®) 2-0 or 3-0 threads on their
periphery, complemented with multiple “mattress pad” adhesion points on
their surface, avoiding folds of the implant. Routinely, absorbable sutures
made of polyglycolic acid 2/0 (Vicryl®) or Polydioxanone (PDS®) 2/0 were
applied subcutaneously to the membranes and muscular aponeurosis along the
entire length of the detached area for immobilization of the flap and
maximum reduction of dead spaces, preventing seromas and promoting the
largest possible contact surface of the membrane-tissue interface. No
suction drains were used in any of the cases in this series.
In cases of inguinal hernias (19 cases), the reinforcement membrane was fixed
to the inguinal canal with 2/0 Prolene stitches and kept buried in a
subfascial position (Figure 1A). When closing the aponeurosis, 2/0 Vicryl® stitches
were applied, plicating the membrane as described. The average size of the
implants was 10 x 6cm.
Figure 1 - A: Intraoperative inguinal hernia repair. View
of the membrane fixed in the inguinal canal below the muscular
fascia (black arrows) that will be sutured, “burying” the
implant in a subfascial position. B: Acellular
membrane implant in a suprafascial position sutured directly
onto the muscular wall after primary approximation of the
muscles. C: Intraoperative appearance of an
incisional hernia with a “ring” opening in the wall measuring
approximately 10cm in diameter, making it impossible to close by
directly approximating the muscle layers. D:
Correction of the reported defect in C with a “bridge” implant,
fixing the membrane under tension along the entire edge of the
hernial ring, directly covering the peritoneum.
Figure 1 - A: Intraoperative inguinal hernia repair. View
of the membrane fixed in the inguinal canal below the muscular
fascia (black arrows) that will be sutured, “burying” the
implant in a subfascial position. B: Acellular
membrane implant in a suprafascial position sutured directly
onto the muscular wall after primary approximation of the
muscles. C: Intraoperative appearance of an
incisional hernia with a “ring” opening in the wall measuring
approximately 10cm in diameter, making it impossible to close by
directly approximating the muscle layers. D:
Correction of the reported defect in C with a “bridge” implant,
fixing the membrane under tension along the entire edge of the
hernial ring, directly covering the peritoneum.
In umbilical and epigastric hernias (5 cases), it was possible to make a
direct primary approximation of the muscles and aponeurosis, with separate
sutures of 1/0 poliglecaprone (Caprofyl®), with the membrane affixed in a
suprafascial position, sutured, covering the treated
area with separate threads. of Prolene 3/0 (Figure 1B). The average size of the implants was 6 x 6cm.
In 3 incisional hernias, the same procedure was used, with the membranes in a
suprafascial position and an average size of 10 x 10cm. In one case, primary
approximation of the muscles was not possible, with the membrane being
exceptionally positioned in a bridge, directly sutured under tension
externally to the edges of the hernial ring and over the peritoneum (Figures 1C and D).
In repairs due to exaggerated compliance of the wall (8 cases) and post-tumor
resection reconstruction (1 case), after horizontal and vertical muscle
plication with 1-0 absorbable threads of Caprofyl® or polydioxanone (PDS®),
the membranes were sutured in position suprafascial with 3/0 Prolene
stitches. These cases required the largest membranes - 15 x 10cm - as well
as the need to use more than one membrane, with supra and infraumbilical
positioning in 3 cases.
RESULTS
Clinical evaluations
The patients presented good results, with no recurrence of herniations in any
of the cases, both clinically and radiologically. There were also no records
of bruises, infections or any phenomenon of a local or systemic reaction
nature. In 1 case, the patient presented infraumbilical seroma, treated by
needle aspiration with the removal of 60ml of secretion, without other
recurrences.
Three patients underwent late reoperation, 2 for scar revision at 13 and 22
months postoperatively, and 1 for post-endometrioma resection revision at 23
months. In all cases, it was not possible to visually identify the
previously implanted membrane, which was then incorporated into the
recipient bed, with a normal appearance, without reactional areas, and with
slight surgical fibrosis in the region. In all cases, biopsies were taken in
the region corresponding to the previous implantation of the membrane.
Radiological evaluations
Ultrasounds carried out at different periods did not allow any identification
of the implanted membranes, even early on. In the first 30 days after
surgery, small, scattered seromas could be observed in the area of the
implants, with no clinical relevance, disappearing after this period. No
long-term local recurrences were observed, nor were there any anatomical
changes in the operated region (Figures 2A-D).
Figure 2 - A, B, C and D: Ultrasound images of
the abdominal wall, post-repair associated with implantation of
acellular bovine pericardial membrane, at different
postoperative periods. Images in A, 15 days after inguinal
herniorrhaphy, and B, 30 days after incisional herniorrhaphy,
showing small isolated seromas without clinical repercussion or
need for drainage. In C and D, images at 45 and 150 days showing
normal appearance after repair of incisional hernias, with no
recurrence or anatomical changes. The arrows identify the
subcutaneous/muscular aponeurosis interface, with the usual
anatomical appearance. In none of the cases did the technique
allow visualization of the implanted membranes.
Figure 2 - A, B, C and D: Ultrasound images of
the abdominal wall, post-repair associated with implantation of
acellular bovine pericardial membrane, at different
postoperative periods. Images in A, 15 days after inguinal
herniorrhaphy, and B, 30 days after incisional herniorrhaphy,
showing small isolated seromas without clinical repercussion or
need for drainage. In C and D, images at 45 and 150 days showing
normal appearance after repair of incisional hernias, with no
recurrence or anatomical changes. The arrows identify the
subcutaneous/muscular aponeurosis interface, with the usual
anatomical appearance. In none of the cases did the technique
allow visualization of the implanted membranes.
In electromagnetic resonances, carried out at 9, 11, 17, and 26 months
postoperatively, it was also not possible to identify the membranes in the
implantation region, as well as indirect signs of their presence. No local
recurrences or important anatomical changes in the operated areas were
identified (Figures 3A-D).
Figure 3 - A, B, C and D: Electromagnetic
resonance imaging of the abdominal wall, post-repair associated
with acellular bovine pericardial membrane implant, at different
postoperative periods. In A, 9 months after post-bariatric
abdominoplasty surgery; in B, 11 months after repair by
resection of infraumbilical wall endometrioma; in C and D, at 17
and 26 months after incisional hernia repair. In all cases, the
membranes were fixed in a suprafascial position, and the cuts
corresponded to the implantation areas. In A, C, and D, the
normal anatomy of the abdominal wall is observed, with the
absence of diastasis of the rectus abdominis muscles (red
arrows), seromas, herniations, or other changes. In B, C, and D,
the subcutaneous/aponeurosis interface is clearly observed,
presenting a normal appearance, and it is not possible to
identify the presence of the implanted membranes.
Figure 3 - A, B, C and D: Electromagnetic
resonance imaging of the abdominal wall, post-repair associated
with acellular bovine pericardial membrane implant, at different
postoperative periods. In A, 9 months after post-bariatric
abdominoplasty surgery; in B, 11 months after repair by
resection of infraumbilical wall endometrioma; in C and D, at 17
and 26 months after incisional hernia repair. In all cases, the
membranes were fixed in a suprafascial position, and the cuts
corresponded to the implantation areas. In A, C, and D, the
normal anatomy of the abdominal wall is observed, with the
absence of diastasis of the rectus abdominis muscles (red
arrows), seromas, herniations, or other changes. In B, C, and D,
the subcutaneous/aponeurosis interface is clearly observed,
presenting a normal appearance, and it is not possible to
identify the presence of the implanted membranes.
Histological evaluations
In all samples, biopsies showed tissue neoformation replacing the implanted
membranes, with significant deposition of collagen and normal-looking
cellularized tissue, with no important reactional aspects observed. The
findings and morphometric and statistical analyses are described in detail
in a parallel publication to this one (part II).
DISCUSSION
Acellular biological matrices have been increasingly used not only in the
reconstruction of the abdominal wall but also in various therapeutic
applications, revealing a conceptual evolution in the application of
biomaterials. The nature of the three-dimensional molecular organization
distinguishes biological extracellular matrix templates from synthetic materials
due to the possibility of repair through tissue remodeling instead of scar
fibrosis, strategies pursued by the concepts of tissue engineering and
regenerative medicine14.
Bovine pericardium has been successfully adopted for this purpose, with a
relative advantage over synthetic materials due to its ability to be
incorporated into surrounding tissues, demonstrating resistance to infection,
extrusion, erosion, and formation of visceral adhesions15-17. Acellular membranes have been particularly indicated
in the presence of contaminated wounds and situations of direct contact between
the implant and the viscera18,19.
The results observed allow us to state that the pericardium matrix used had
similar behavior to that documented in the literature, presenting functionality
in correcting defects without recording recurrences or reactional events and
integration with adjacent tissues, with the neotissue offering mechanical
resistance satisfactory in the long term. It was possible to directly observe
the total incorporation of the membranes during reoperations, in addition to
the
results described in the radiological evaluations. In this aspect, although
attesting to the anatomical integrity of the operated sites, the matrices were
not visualized by ultrasound from 15 days after surgery, as well as by
electromagnetic resonance from 9 months onwards, thus revealing the
ineffectiveness of the methods as a tool for evaluation of ECMs in the
postoperative period.
The protocol adopted did not allow for a comparative evaluation of the membranes
in more complex repairs and in contaminated wounds. However, due to the
similarity presented with the general characteristics of ECMs described in the
available literature, their indication can be considered without restrictions
in
future repairs of the abdominal wall in those conditions. Deliberately, the
protocol limited the indications to lower-risk cases, classified as Grade
I20, limiting
comorbidities that could interfere with the evaluation of the implant itself
in
the event of complications.
It is estimated that up to 75% of complications are due to infection, seromas,
and inadequate implant fixation21,22, justifying
the preventive methodology adopted. The routine prevention of biofilm
formation23, a common
cause of adverse events in the use of implants, justifies the rigorous adoption
of the “no touch” concept intraoperatively24,25. The same applies to the prevention of seromas and
implant fixation, with “subcutaneous/implant/aponeurosis” adhesion points
efficiently fulfilling several objectives.
With the immediate immobilization of the flap and implant, slippage is prevented,
and the greatest possible contact of the membrane/tissue interface is promoted,
favoring the biological processes of membrane repair and incorporation.
Furthermore, the presence of “dead space” in the detachment plane is reduced
as
much as possible, preventing seromas and simultaneously eliminating the need
for
drains.
No aspiration drains were used in any of the cases in this series, and in only
one case, there was a need for aspiration puncture to treat a small seroma.
Ultrasounds performed at different postoperative periods show small, scattered
seromas present in the first 30 days, not being observed in late cases, with
a
normal-looking subcutaneous/aponeurosis interface without visualization of the
membranes.
Besides being more comfortable for the patient the absence of drains, its use may
favor contamination of the surgical site, and its effectiveness in preventing
seromas has not been adequately demonstrated26,27, with use
restricted to exceptional indications. The results obtained confirm that
rigorous fixation of the subcutaneous/aponeurosis/implant interface, with
progressive adhesion sutures of the entire detached area28, can eliminate the need for
aspiration drains in abdominal wall repairs in the presence of implants.
Technical aspects in the placement and positioning of implants in relation to the
muscular plane - subfascial, suprafascial, submuscular, or “bridged” - are
factors described that can also increase the risk of complications29,30. In the cases operated on in this series, the membranes
were implanted in the subfascial space for inguinal and suprafascial hernias
in
protrusions and repairs of incisional hernias with primary approximation of the
muscles, being kept in bridge exceptionally in only 1 case. Aided by fixation
methods, the results show that suprafascial fixation of bioprostheses is a
simple and effective method for correcting less complex ventral hernias, as
described in other publications31, as well as in common cases due to exaggerated compliance
of the abdominal wall (Video
1ttp://rbcp.org.br/Content/imagebank/video/REPARA%C3%87%C3%83O DA PAREDE
ABDOMINAL.mp4).
Biological prostheses must be biodegraded by the action of
metalloproteases32 and
replaced by native tissues over time, serving as a temporary structure for the
growth of host cells. If the implant is absorbed before adequate processes of
neovascularization, tissue growth, and collagen differentiation/deposition, the
quality of the neotissue will compromise the expected result, a concept that
determines the functionality of the implants.
In this context, discussions focus on whether or not to cross-link ECMs for
abdominal wall repairs33,34 due to different biological
behaviors. Non-cross-linked matrices present faster
incorporation and reabsorption35, while cross-linking prolongs degradation
time and increases mechanical resistance36,37.
Studies have shown that EMCs cross-linked with glutaraldehyde have greater
resistance to collagenase, with slower degradation, particularly in contaminated
environments38,39, which is why they have been
the first choice to be considered in these situations for more than a
decade21,40. Studies with acellularized
bovine pericardium demonstrated a direct relationship between the degree of
cross-linking and resistance to degradation, which is decisive in the
degradation kinetics and the pattern of tissue regeneration41,42, making it seem logical to adopt cross-linked
bioprostheses in regions of greater mechanical stress, such as the abdominal
wall.
The glutaraldehyde cross-linked matrix used in this study showed similar
properties to other bioprostheses reported in terms of progressive material
degradation requirements versus mechanical resistance of the newly formed
tissue. In addition to the clinical and radiological findings, direct
visualization of the reoperated sites showed the intact wall with good quality
scar tissue, without adhesions or important inflammatory processes, with the
implanted membranes fully incorporated.
Extracellular matrices represent a microenvironmental niche with important
biological activities in tissue regeneration processes43, going beyond the merely structural issue of
mechanical support. With implantation, processes begin that impact local
biological activity with cellular recruitment and immune response44-46, favoring an environment of functional remodeling
rather than scarring fibrosis or chronic inflammatory processes.
Unlike the exclusively mechanical role of synthetic implants, bioprostheses play
an active role in in situ biological events, pointing towards
regenerative processes that must be properly known and experienced by surgeons,
whose experience is estimated as one of the most important prognostic factors
in
the correction of abdominal wall hernias47.
CONCLUSION
The acellular bovine pericardium matrix was effective in correcting abdominal
wall defects, attesting to its functionality and similarity to other
bioprostheses described in the literature.
Ultrasound and electromagnetic resonance examinations proved to be ineffective
methods as a tool for evaluating EMCs in the postoperative period.
“Subcutaneous/implant/aponeurosis” fixation points throughout the detached area
may eliminate the need for aspiration drains in the presence of bovine
pericardial bioprostheses implanted in a suprafascial position.
The use of extracellular matrices brings important conceptual developments that
must be incorporated by surgeons, with the choice of bioprostheses having to
be
considered factors that go beyond the cost-benefit ratio of the procedures.
Series with a greater number of cases and complex reconstructions will be able
to define the criteria for its indication better.
REFERENCES
1. Everling EM, Bandeira DS, Gallotti FM, Bossardi P, Tonatto-Filho AJ,
Grezzana-Filho TJM. Open vs laparoscopic hernia repair in the Brazilian public
health system. An 11-year nationwide population-based study. Arq Gastroenterol.
2020;57(4):484-90.
2. Rohrich RJ, Lowe JB, Hackney FL, Bowman JL, Hobar PC. An algorithm
for abdominal wall reconstruction. Plast Reconstr Surg.
2000;105(1):202-16.
3. Beale EW, Hoxworth RE, Livingston EH, Trussler AP. The role of
biologic mesh in abdominal wall reconstruction: a systematic review of the
current literature. Am J Surg. 2012;204(4):510-7.
4. Burcharth J, Pommergaard HC, Bisgaard T, Rosenberg J.
Patient-related risk factors for recurrence after inguinal hernia repair: a
systematic review and meta-analysis of observational studies. Surg Innov.
2015;22(3):303-17.
5. Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM,
IJzermans JN, et al. A comparison of suture repair with mesh repair for
incisional hernia. N Engl J Med. 2000;343(6):392-8.
6. DeBord JR. The historical development of prosthetics in hernia
surgery. Surg Clin North Am. 1998;78(6):973-1006.
7. Janis JE, O’Neill AC, Ahmad J, Zhong T, Hofer SOP. Acellular dermal
matrices in abdominal wall reconstruction: a systematic review of the current
evidence. Plast Reconstr Surg. 2012;130(5 Suppl 2):183S-193S.
8. Wainwright D, Madden M, Luterman A, Hunt J, Monafo W, Heimbach D, et
al. Clinical evaluation of an acellular allograft dermal matrix in
full-thickness burns. J Burn Care Rehabil. 1996;17(2):124-36.
9. Cicilioni O Jr, Araujo G, Mimbs N, Cox MD. Initial experience with
the use of porcine acellular dermal matrix (Strattice) for abdominal wall
reinforcement after transverse rectus abdominis myocutaneous flap breast
reconstruction. Ann Plast Surg. 2012;68(3):265-70.
10. Armitage S, Seman EI, Keirse MJ Use of surgisis for treatment of
anterior and posterior vaginal prolapse. Obstet Gynecol Int. 2012;2012:376251.
DOI: 10.1155/2012/376251
11. Eichler C, Vogt N, Brunnert K, Sauerwald A, Puppe J, Warm M. A
Head-to-head Comparison between SurgiMend and Epiflex in 127 Breast
Reconstructions. Plast Reconstr Surg Glob Open. 2015;3(6):e439.
12. Limpert JN, Desai AR, Kumpf AL, Fallucco MA, Aridge DL. Repair of
abdominal wall defects with bovine pericardium. Am J Surg. 2009;198(5):e60-5.
DOI: 10.1016/j.amjsurg.2009.01.027
13. Braile Biomédica. Braile - Life-Saving Trechnologies. Nossa história
[Internet]. São José do Rio Preto (SP): Braile Biomédica; 2021; [acesso em 2024
Jan 31]. Disponível em: https://braile.com.br/nossa-historia
14. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a
biological scaffold material: Structure and function. Acta Biomater.
2009;5(1):1-13.
15. Clemens MW, Selber JC, Liu J, Adelman DM, Baumann DP, Garvey PB, et
al. Bovine versus porcine acellular dermal matrix for complex abdominal wall
reconstruction. Plast Reconstr Surg. 2013;131(1):71-9.
16. Garvey PB, Martinez RA, Baumann DP, Liu J, Butler CE. Outcomes of
abdominal wall reconstruction with acellular dermal matrix are not affected by
wound contamination. J Am Coll Surg. 2014;219(5):853-64.
17. Butler CE. The role of bioprosthetics in abdominal wall
reconstruction. Clin Plast Surg. 2006;33(2):199-211.
18. Law NW, Ellis H. A comparison of polypropylene mesh and expanded
polytetrafluoroethylene patch for the repair of contaminated abdominal wall
defects--an experimental study. Surgery. 1991;109(5):652-5.
19. Costa A, Naranjo JD, Londono R, Badylak SF. Biologic Scaffolds. Cold
Spring Harb Perspect Med. 2017;7(9):a025676. DOI:
10.1101/cshperspect.a025676
20. Mioton LM, Jordan SW, Hanwright PJ, Bilimoria KY, Kim JY. The
Relationship between Preoperative Wound Classification and Postoperative
Infection: A Multi-Institutional Analysis of 15,289 Patients. Arch Plast Surg.
2013;40(5):522-9. DOI: 10.5999/aps.2013.40.5.522
21. Ventral Hernia Working Group; Breuing K, Butler CE, Ferzoco S, Franz
M, Hultman CS, Kilbridge JF, et al. Incisional ventral hernias: review of the
literature and recommendations regarding the grading and technique of repair.
Surgery. 2010;148(3):544-58. DOI: 10.1016/j.surg.2010.01.008
22. Awad ZT, Puri V, LeBlanc K, Stoppa R, Fitzgibbons RJ Jr, Iqbal A, et
al. Mechanisms of ventral hernia recurrence after mesh repair and a new proposed
classification. J Am Coll Surg. 2005;201(1):132-40.
23. Khatoon Z, McTiernan CD, Suuronen EJ, Mah TF, Alarcon EI. Bacterial
biofilm formation on implantable devices and approaches to its treatment and
prevention. Heliyon. 2018;4(12):e01067. DOI: 10.1016/j.heliyon.
2018.e01067
24. Ajdic D, Zoghbi Y, Gerth D, Panthaki ZJ, Thaller S. The Relationship
of Bacterial Biofilms and Capsular Contracture in Breast Implants. Aesthet Surg
J. 2016;36(3):297-309. DOI: 10.1093/asj/sjv177
25. Kao AM, Arnold MR, Augenstein VA, Heniford BT. Prevention and
Treatment Strategies for Mesh Infection in Abdominal Wall Reconstruction. Plast
Reconstr Surg. 2018;142(3 Suppl):149S-155S. DOI:
10.1097/PRS.0000000000004871
26. White TJ, Santos MC, Thompson JS. Factors affecting wound
complications in repair of ventral hernias. Am Surg.
1998;64(3):276-80.
27. Gurusamy KS, Allen VB, Samraj K. Wound drains after incisional
hernia repair. Cochrane Database Syst Rev. 2012;15(2):CD005570. DOI:
10.1002/14651858.CD005570.pub3
28. Baroudi R, Ferreira CA. Seroma: how to avoid it and how to treat it.
Aesthet Surg J. 1998;18(6):439-41. DOI:
10.1016/s1090-820x(98)70073-1
29. Kingsnorth A. The management of incisional hernia. Ann R Coll Surg
Engl. 2006;88(3):252-60.
30. Korenkov M, Paul A, Sauerland S, Neugebauer E, Arndt M, Chevrel JP,
et al. Classification and surgical treatment of incisional hernia. Results of
an
experts’ meeting. Langenbecks Arch Surg. 2001;386(1):65-73.
31. Jin J, Rosen MJ, Blatnik J, McGee MF, Williams CP, Marks J, et al.
Use of acellular dermal matrix for complicated ventral hernia repair: does
technique affect outcomes? J Am Coll Surg. 2007;205(5):654-60. DOI:
10.1016/j.jamcollsurg.2007.06.012
32. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell
behavior. Annu Rev Cell Dev Biol. 2001;17:463-516.
33. Smart NJ, Bloor S. Durability of biologic implants for use in hernia
repair: a review. Surg Innov. 2012;19(3):221-9.
34. de Castro Brás LE, Shurey S, Sibbons PD. Evaluation of crosslinked
and non-crosslinked biologic prostheses for abdominal hernia repair. Hernia.
2012;16(1):77-89.
35. Mestak O, Spurkova Z, Benkova K, Vesely P, Hromadkova V, Miletin J,
et al. Comparison of Cross-linked and Non-Cross-linked Acellular Porcine Dermal
Scaffolds for Long-term Full-Thickness Hernia Repair in a Small Animal Model.
Eplasty. 2014;14:e22.
36. Gaertner WB, Bonsack ME, Delaney JP. Experimental evaluation of four
biologic prostheses for ventral hernia repair. J Gastrointest Surg.
2007;11(10):1275-85.
37. Smart NJ, Daniels IR, Marquez S. Supplemental cross-linking in
tissue-based surgical implants for abdominal wall repair. Int J Surg.
2012;10(9):436-42. DOI: 10.1016/j.ijsu.2012.07.010
38. Valentin JE, Badylak JS, McCabe GP, Badylak SF. Extracellular matrix
bioscaffolds for orthopaedic applications. A comparative histologic study. J
Bone Joint Surg Am. 2006;88(12):2673-86.
39. Catena F, Ansaloni L, Gazzotti F, Gagliardi S, Di Saverio S,
D’Alessandro L, et al. Use of porcine dermal collagen graft (Permacol) for
hernia repair in contaminated fields. Hernia. 2007;11(1):57-60.
40. Sartelli M, Coccolini F, van Ramshorst GH, Campanelli G, Mandalà V,
Ansaloni L, et al. WSES guidelines for emergency repair of complicated abdominal
wall hernias. World J Emerg Surg. 2013;8(1):50. DOI:
10.1186/1749-7922-8-50
41. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ.
Development of a pericardial acellular matrix biomaterial: biochemical and
mechanical effects of cell extraction. J Biomed Mater Res.
1994;28(6):655-66.
42. Liang HC, Chang Y, Hsu CK, Lee MH, Sung HW. Effects of crosslinking
degree of an acellular biological tissue on its tissue regeneration pattern.
Biomaterials. 2004;25(17):3541-52. DOI:
10.1016/j.biomaterials.2003.09.109
43. Hoganson DM, Owens GE, O’Doherty EM, Bowley CM, Goldman SM, Harilal
DO, et al. Preserved extracellular matrix components and retained biological
activity in decellularized porcine mesothelium. Biomaterials.
2010;31(27):6934-40.
44. Huleihel L, Hussey GS, Naranjo JD, Zhang L, Dziki JL, Turner NJ, et
al. Matrix-bound nanovesicles within ECM bioscaffolds. Sci Adv.
2016;2(6):e1600502.
45. Crapo PM, Tottey S, Slivka PF, Badylak SF. Effects of biologic
scaffolds on human stem cells and implications for CNS tissue engineering.
Tissue Eng Part A. 2014;20(1-2):313-23.
46. Brown BN, Badylak SF. Extracellular matrix as an inductive scaffold
for functional tissue reconstruction. Transl Res.
2014;163(4):268-85.
47. Langer C, Schaper A, Liersch T, Kulle B, Flosman M, Füzesi L, et al.
Prognosis factors in incisional hernia surgery: 25 years of experience. Hernia.
2005;9(1):16-21. DOI 10.1007/s10029-004-0265-y
1. Hospital do Coração de São José do Rio Preto,
São José do Rio Preto, SP, Brazil
2. Sociedade Portuguesa de Beneficência de São
José do Rio Preto, São José do Rio Preto, SP, Brazil
3. Hospital Estadual João Paulo II, São José do
Rio Preto, SP, Brazil
Corresponding author: Luiz Fernando Frascino Av.
Juscelino Kubitscheck de Oliveira, 3700, São José do Rio Preto, SP, Brazil, Zip
Code: 15093-225, E-mail: drfrascino@gmail.com
Article received: March 14, 2023.
Article accepted: October 23, 2023.
Conflicts of interest: none.